Oxazepam
NDC Package 16590-304-30

11-digit billing NDC: 16590030430

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Oxazepam is iNDICATIONS AND USAGEOxazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Marketed by Stat Rx Usa Llc, this product is identified by NDC 16590-304 and is authorized under FDA application ANDA072252.

Identification & Billing

NDC Package Code
16590-304-30
Package Description
30 CAPSULE in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
16590030430
RxNorm Crosswalk
RxCUI: 312134 - oxazepam 15 MG Oral Capsule

Clinical Specifications

Proprietary Name
Oxazepam
Dosage Form
-
Usage Information
INDICATIONS AND USAGEOxazepam is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic.Anxiety associated with depression is also responsive to Oxazepam therapy.This product has been found particularly useful in the management of anxiety, tension, agitation, and irritability in older patients.Alcoholics with acute tremulousness, inebriation, or with anxiety, associated with alcohol withdrawal are responsive to therapy.The effectiveness of Oxazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.

Regulatory & Marketing

Labeler Name
Stat Rx Usa Llc
FDA Application #
ANDA072252
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-14-1988
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (16590-304). Click a package code to view its specific billing and regulatory data.

60 CAPSULE in 1 BOTTLE, PLASTIC
90 CAPSULE in 1 BOTTLE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 16590-304-30 identifies a specific commercial package of 30 capsule in 1 bottle, plastic of Oxazepam, labeled by Stat Rx Usa Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Stat Rx Usa Llc on April 14, 1988. The current certification is valid through December 31, 2017.

How is this Stat Rx Usa Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 16590030430. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
16590-304-30
11-Digit CMS (5-4-2)
16590-0304-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.